![Matthew Klein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Klein
Algemeen Directeur bij PTC THERAPEUTICS, INC.
Vermogen: 3 M $ op 30-11-2024
Profiel
Matthew B.
Klein is currently the President, Chief Executive Officer & Director at PTC Therapeutics, Inc. He is also an Independent Director at Clearpoint Neuro, Inc. Additionally, he holds positions as a Director at PTC Therapeutics International Ltd.
and as a Clinical Associate Professor at Stanford University.
Previously, he served as the Chairman-Restorative Burn Surgery at the University of Washington.
He was also a Director at BioElectron Technology Corp.
from 2019 to 2020 and held the position of Chief Medical Officer & Senior Vice President at Edison Pharmaceuticals, Inc. Dr. Klein obtained his undergraduate degree from the University of Pennsylvania, his doctorate from Yale University, and his graduate degree from UW School of Public Health.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
PTC THERAPEUTICS, INC.
0.07% | 22-04-2024 | 52 475 ( 0.07% ) | 2 M $ | 30-11-2024 |
CLEARPOINT NEURO, INC.
0.11% | 16-05-2024 | 29 425 ( 0.11% ) | 363 987 $ | 30-11-2024 |
Laatste nieuws over Matthew Klein
Actieve functies van Matthew Klein
| Bedrijven | Functie | Begin |
|---|---|---|
| CLEARPOINT NEURO, INC. | Directeur/Bestuurslid | 16-04-2020 |
| PTC THERAPEUTICS, INC. | Algemeen Directeur | 22-03-2023 |
| Stanford University | Corporate Officer/Principal | - |
| PTC Therapeutics International Ltd. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Matthew Klein
| Bedrijven | Functie | Einde |
|---|---|---|
BioElectron Technology Corp.
 BioElectron Technology Corp. Miscellaneous Commercial ServicesCommercial Services BioElectron Technology Corp. is a clinical-stage biotechnology company, which engages in the research and development of therapeutics for inherited mitochondrial disease. The company was founded in 2005 and is headquartered in Mountain View, CA. | Algemeen Directeur | 01-01-2019 |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
Edison Pharmaceuticals, Inc.
 Edison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Edison Pharmaceuticals, Inc. developed drugs to treat mitochondrial diseases. It offers EPI-743 and EPI-A0001, an orally absorbed small molecules. The company was founded by Guy Miller in 2005 and was headquartered in Mountain View, CA. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Matthew Klein
| Yale University | Doctorate Degree |
| University of Pennsylvania | Undergraduate Degree |
| UW School of Public Health | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| CLEARPOINT NEURO, INC. | Health Technology |
| PTC THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Edison Pharmaceuticals, Inc.
Edison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Edison Pharmaceuticals, Inc. developed drugs to treat mitochondrial diseases. It offers EPI-743 and EPI-A0001, an orally absorbed small molecules. The company was founded by Guy Miller in 2005 and was headquartered in Mountain View, CA. | Health Technology |
BioElectron Technology Corp.
BioElectron Technology Corp. Miscellaneous Commercial ServicesCommercial Services BioElectron Technology Corp. is a clinical-stage biotechnology company, which engages in the research and development of therapeutics for inherited mitochondrial disease. The company was founded in 2005 and is headquartered in Mountain View, CA. | Commercial Services |
| PTC Therapeutics International Ltd. |
